Recommendations for postmarketing surveillance studies in haemophilia and other bleeding disorders-Reference-Cited by-同舟云学术

Recommendations for postmarketing surveillance studies in haemophilia and other bleeding disorders

Published:2005-07 Issue:4 Volume:11 Page:353-359
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Lassila R.,Rothschild C.,Moerloose P.,Richards M.,Perez R.,Gajek H.,

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2516.2005.01114.x/fullpdf

Reference23 articles.

1. 2ICH Harmonised Tripartite Guidelines, Guideline for Good Clinical Practice . International Conference on Harmonisation of Technical Requirements for registration of Pharmaceuticals for Human Use 1996 . http://www.emea.eu.int/pdfs/human/ich/013595en.pdf.

2. Arthritis Medicines and Cardiovascular Events—“House of Coxibs”

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment highlights need for improvement in standards of development of core outcome sets for rare genetic diseases;Journal of Clinical Epidemiology;2023-09

2. Discussing investigational AAV gene therapy with hemophilia patients: A guide;Blood Reviews;2021-05

3. Opioid analgesic dose and the risk of misuse, overdose, and death: A narrative review;Pharmacoepidemiology and Drug Safety;2017-12-15

4. Challenges of post-authorization safety studies: Lessons learned and results of a French study of fentanyl buccal tablet;Pharmacoepidemiology and Drug Safety;2017-10-13

5. An innovative outcome-based care and procurement model of hemophilia management;Expert Review of Pharmacoeconomics & Outcomes Research;2016-05-03